Sort
40,608 grants matching “prostate cancer”
Molecular and immune drivers of immunotherapy responsiveness in prostate cancer
$844,999Eliezer M Van Allen · Dana-Farber Cancer Inst · U01 · FY2022 · CA
Molecular and immune drivers of immunotherapy responsiveness in prostate cancer
$844,999Eliezer M Van Allen · Dana-Farber Cancer Inst · U01 · FY2020 · CA
Investigating the Roles of Patient Beliefs, and Physician Communication on Disparities in Lung Cancer Screening
$844,984Minal S Kale · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · MD
NOVEL IMMUNOTHERAPY COMBINATIONS AGAINST CASTRATION-RESISTANT PROSTATE CANCER
$843,940The Univeristy Of Texas M.D. Anderson Cancer Center · · FY2019 · Defense Health Agency
Zinc-Based Early Detection of Prostate Cancer
$843,513Christopher J Frederickson · Neurobiotex, Inc. · R44 · FY2008 · CA
Harvard/Michigan Prostate Cancer Biomarker Clinical Ctr
$843,497Martin G Sanda · Beth Israel Deaconess Medical Center · U01 · FY2009 · CA
Virginia-UCLA-Toronto Biomarker Characterization Center
$843,355Oliver John Semmes · Old Dominion University · U2C · FY2025 · CA
Clinical trials employing cancer vaccine combination therapies
$843,113James L. Gulley · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Cancer Therapy Clinical Trials Using Novel Recombinant Vaccines
$843,113James L. Gulley · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
INTEGRATED ULTRASONIC SYSTEMS FOR NONINVASIVE THERAPY
$842,948Riverside Research Institute · R01 · FY2002 · CA
Morphologic, Metabolic and Functional Prostate Imaging
$842,943Daniel B Vigneron · University Of California, San Francisco · R01 · FY2006 · CA
Molecular and immune drivers of immunotherapy responsiveness in prostate cancer
$842,916Eliezer M Van Allen · Dana-Farber Cancer Inst · U01 · FY2019 · CA
Biological Functions of Chromosomal Proteins
$842,732Michael Bustin · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Comparative Effectiveness of Modern Therapies for Localized Prostate Cancer
$842,282David F Penson · Vanderbilt University · R01 · FY2013 · HS
MAGNESIUM PREDICTS HIGH-GRADE PROSTATE CANCER AND A POORER PROGNOSIS AMONG BLACK AND WHITE MEN
$842,215Vanderbilt University Medical Center · · FY2015 · Department of the Army
A Targeted Decision Aid to Improve Minority Participation in Clinical Trials
$841,593Margaret M Byrne · University Of Miami School Of Medicine · RC2 · FY2009 · MD
Center for Applied Preclinical Research (CAPR)
$841,462Terry Van Dyke · Division Of Basic Sciences - Nci · ZIC · FY2012 · CA
Molecular and immune drivers of immunotherapy responsiveness in prostate cancer
$841,459Eliezer M Van Allen · Dana-Farber Cancer Inst · U01 · FY2018 · CA
Night Shift Work and Hormone Levels in Men
$841,297Scott Davis · Fred Hutchinson Cancer Research Center · R01 · FY2010 · CA
Translational Pathology Core Facility
$840,907Sue Ellen Martin · University Of Southern California · P30 · FY2009 · CA
PLCO EEMS and Extended Follow Up
$840,647Robert Hoover · Division Of Cancer Epidemiology And Genetics · ZIA · FY2012 · CA
SENIOR LEADERSHIP
$840,645Joseph Rocco Bertino · Univ Of Med/Dent Nj-R W Johnson Med Sch · P30 · FY2012 · CA
Randomized Trial of Exercise Therapy on Markers of Progression in Localized Prostate Cancer
$839,781Lee W Jones · Beckman Research Institute/City Of Hope · R01 · FY2025 · CA
Targeting Tumor Suppressor Phosphatases For Cancer Therapy
$839,120Pier Paolo Pandolfi · Beth Israel Deaconess Medical Center · U01 · FY2010 · CA
Identification of epigenetic drivers of advanced prostate cancer
$838,796David Takeda · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA